本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Corvus Pharmaceuticals, Inc.

8.91
+0.14001.60%
盘后8.910.00000.00%16:34 EST
成交量:92.04万
成交额:829.68万
市值:6.65亿
市盈率:-15.95
高:9.24
开:8.82
低:8.72
收:8.77
52周最高:9.55
52周最低:2.54
股本:7,468.19万
流通股本:5,735.63万
量比:0.91
换手率:1.60%
股息:- -
股息率:- -
每股收益(TTM):-0.5587
每股收益(LYR):-1.0214
净资产收益率:-35.82%
总资产收益率:-34.87%
市净率:9.27
市盈率(LYR):-8.72

数据加载中...

2022/08/08

重要事件披露

8-K - Current report
2022/08/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/17

重要事件披露

8-K - Current report
2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/10

重要事件披露

8-K - Current report
2022/03/10

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/06

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/11/01

重要事件披露

8-K - Current report
2021/11/01

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals